BioTesserae logo
HealthTech + BioTechHoldco Asset

BioTesserae

πŸ‡ΊπŸ‡ΈUSA
Cohort 2022
biotesserae.com
CURRENT VALUATION
$3M
Mark-to-market holdco book value
ENTRY VALUATION
$1.4M
Pre-seed acceleration round
VINTAGE / COHORT
2022HOLDCO ASSET
Initial entry cohort
ECOSYSTEM TRACK
HealthTech
Global founder cohort

Company Overview

Biotech company developing antiviral and therapeutic biomedical solutions for animal and human health.

Investment Thesis & Acceleration

Expert DOJO backed BioTesserae during early acceleration to scale market distribution, assemble high-conviction syndicates, and expand operations into key international markets. The company exemplifies our core thesis of backing relentless operators solving urgent systemic workflows.

High-Margin ArchitectureAutonomous OperationsGlobal Addressable Market